Details for New Drug Application (NDA): 050813
✉ Email this page to a colleague
The generic ingredient in MOXATAG is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
Summary for 050813
Tradename: | MOXATAG |
Applicant: | Pragma |
Ingredient: | amoxicillin |
Patents: | 3 |
Medical Subject Heading (MeSH) Categories for 050813
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 775MG | ||||
Approval Date: | Jan 23, 2008 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | May 7, 2027 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | USE OF ONCE-A-DAY AMOXICILLIN PRODUCT TO TREAT TONSILLITIS AND/OR PHARYNGITIS SECONDARY TO STREPTOCOCCUS PYOGENES | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Dec 8, 2026 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Dec 8, 2026 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
Patented Use: | METHOD OF TREATING TONSILLITIS AND/OR PHARYNGITIS SECONDARY TO STREPTOCOCCUS PYOGENES IN A ONCE-A-DAY AMOXICILLIN PRODUCT |
Expired US Patents for NDA 050813
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription